CPMV · Mosaic ImmunoEngineering Inc.
$0.06
+0.00 (+0.00%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The above matters raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$441,770
Shares
7.24M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$687.85K
+25.4%
FY2025
Diluted EPS
-$0.10
+23.1%
FY2025
Operating Cash Flow
-$111.4K
+53.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $63.66K | $63.98K | $183.87K | $435.45K | $1.05M | $1.46M | — | — | — | — | — | — | — | — | — | |
| $540.35K | $552.14K | $695.79K | $964.32K | $1.58M | $2.05M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | $996.02K | $734.06K | $1.05M | $1.22M | $1.58M | $1.44M | $1.66M | $1.38M | $1.99M | |
| $604.01K | $616.12K | $879.66K | $1.4M | $2.63M | $3.5M | $996.02K | $734.06K | $1.05M | $1.22M | $1.58M | $1.44M | $1.66M | $1.38M | $1.99M | |
| -$604.01K | -$616.12K | -$879.66K | -$1.4M | -$2.63M | -$3.5M | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $20.81K | |
| -$83.33K | -$69.33K | -$39.93K | $393.93K | $249.05K | -$180.91K | -$62.91K | -$62.8K | -$212.08K | $1.17M | $312.27K | -$96.78K | $110.16K | $2.47M | -$1.46M | |
| — | — | — | — | — | — | -$74.98K | -$91.51K | -$242.62K | $1.16M | $297.7K | -$106.92K | $104.68K | $2.17M | -$1.83M | |
| -$687.35K | -$685.45K | -$919.58K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$796.86K | -$1.26M | -$42.97K | -$1.26M | -$1.53M | -$1.55M | $1.08M | -$3.46M | |
| $0 | $2400 | $2400 | $2400 | $2400 | $2400 | $1600 | $1600 | -$49.76K | $2400 | $2400 | $1570 | $5999 | -$113 | -$875 | |
| -$687.35K | -$687.85K | -$921.98K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$798.46K | -$1.21M | -$45.37K | -$1.27M | -$1.54M | -$1.47M | $1.1M | -$4.82M | |
| USD/shares | -$0.09 | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| USD/shares | -$0.09 | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — |
| shares | — | 7.24M | 7.24M | 7.24M | 7.24M | 6.71M | 797.1K | 797.1K | 797.1K | 797.1K | 797.1K | 797.1K | 802.9K | 805.05K | 807.25K |
| shares | — | — | 7.24M | 7.24M | 7.24M | 6.71M | 797.1K | 797.1K | 797.1K | 797.1K | — | — | — | — | 807.25K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2012–FY2015: $402.83K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 5.65×
EV/EBIT
—
Biotechnology median 23.21×
P/E (TTM)
—
Biotechnology median 17.50×